Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens.
NCT ID: NCT06101472
Last Updated: 2024-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
63 participants
OBSERVATIONAL
2024-02-29
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Information will be obtained from patients operated by routine clinical practice with toric monofocal ASQELIO IOL in at least one eye. After confirmation of inclusion, the preoperative examination will be performed, and after surgery an evaluation will be performed the following day, one week, one month and three months after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Results of Asqelio Trifocal Toric Diffractive Intraocular Lens
NCT06190925
Safety and Efficacy of the Hydrophobic Intraocular Lens Asqelio Monofocal With Biaspheric Design
NCT06056154
Visual Quality and Performance of Eyes With Asqelio™ EDoF Toric Lenses
NCT06707545
Clinical Results of Asqelio™ EDOF Toric Soft Hydrophobic Intraocular Lens After Cataract Surgery
NCT06229756
Clinical Behavior of the Asqelio™ Trifocal Diffractive Intraocular Lens
NCT05776446
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients participating in the study are candidates for cataract surgery with ASQUELIO Toric intraocular lens (IOL) implantation model TLIO130 from AST Products, Inc., with CE marking.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pseudophakic subjects implanted with the ASQELIO toric IOL
Adult subjects undergoing cataract surgery by routine clinical practice with ASQELIO Toric Biaspheric Monofocal Lens in at least one eye.
ASQELIO Toric Biaspheric Monofocal Lens
Intraocular lens implantation in cataract surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ASQELIO Toric Biaspheric Monofocal Lens
Intraocular lens implantation in cataract surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects for whom postoperative emmetropia was planned (±0.5 D spherical equivalent)
Exclusion Criteria
* Patients who do not provide informed consent
* Patients who do not understand the study procedure.
* Previous corneal surgery or trauma.
* Irregular cornea (e.g. keratoconus).
* Microphthalmos.
* Severe corneal dystrophy.
* Pregnant or breastfeeding'.
* Rubella
* Mature/dense cataract making eye bottom preoperative examination difficult.
* Previous retinal detachment.
* Concurrent participation in other research with drugs or clinical devices.
* Expect to require another eye surgery during the study period.
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AST Products, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedro Tañá, Dr
Role: PRINCIPAL_INVESTIGATOR
Oftalmología Vistahermosa SL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oftalvist Alicante
Alicante, , Spain
OftalVist Madrid
Madrid, , Spain
OftalVist Valencia
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
José M Rubio, OD
Role: primary
Fátima Martínez Galdón, OD
Role: primary
Rafael Pastor Pascual, OD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASQM022023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.